The 10th batch of national centralized drug procurement opened for tender in Shanghai yesterday (12th), resulting in the proposed selection. The procurement of 62 kinds of drugs was successful, while 385 products of 234 enterprises won the proposed selection qualification, involving areas such as hypertension, diabetes, tumor and cardiovascular disease. Related NewsCSPC PHARMA (01093.HK) 1Q26 Basic Profit Falls 40.3% YoY to RMB842 millionThe results will be officially released after the public announcement.
AASTOCKS Financial News